The EMA, which is the EU’s equivalent to the Food and Drug Administration, is currently located in London. The agency is expected to have to relocate due to Britain’s exit from the EU.
Philippe Richert, president of Grand Est regional council in eastern France, asked French President Francois Hollande to nominate Strasbourg as the new location for the EMA.
European lawmaker Françoise Grossetete requested that the EMA move to Lyon since several drug companies, including Sanofi, are based there.
These aren’t the first cities to put their hats into the ring — Milan, Madrid, Stockholm, Warsaw and Vienna have all expressed interest in being the new home of the EMA, acknowledging the advantage of having close ties with the regulator.
More articles on supply chain:
Blood banks hit by Zika donor rules, leaving some regions in critical shortage
FDA approves Abbott’s fully dissolving heart stent
Pfizer agrees to acknowledge addiction risks in opioid marketing
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
